Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica

NCT06558357 | Not Yet Recruiting

• 1 other identifier: 29BRC24.0172 - RHUMATEP
• Study Type: observational
• Target: 210
• Locations: 1 country
• Sites: 1

Brief Summary

Study of the diagnostic performance of 18-FDG PET scores in Polymyalgia rheumatica and comparaison with others inflammatories diseases.

Conditions

Inflammatory Rheumatism; 18-FDG; Positron-emission Tomography

Keywords

Polymyalgia rheumatica; FDG; PET; Diagnostic performance; score

Outcome Measures

Primary Outcomes (1)

• Diagnostic performance of 18-FDG PET scores for diagnostic of Polymyalgia rheumatica.

  Evaluation of the metabolism of mains joints compared to liver. Calculation of different scores described in literature.

  up to 9 months

Secondary Outcomes (3)

• Analysis of SUV and visual fixation of mains joints.

  up to 9 months

• Diagnostic performance of 18-FDG PET scores for diagnostic of others inflammatory rheumatism.

  up to 9 months

• Comparaison of scores with clinical, biological and radiological data.

  up to 9 months

Eligibility Criteria

• Age: 18 Years - 110 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult with inflammatory rheumatism confirmed by specialist, with or without treatment and having a 18-FDG-PET CT.

You may qualify if:

• Having 18-FDG PET-CT between 2012 and 2024
• Diagnosis of inflammatory rheumatism by specialist doctor
• Adult without opposition to use there data for research
• Affiliate to social security system

You may not qualify if:

• Refusal participation
• Patient under juridic protection

Sponsors & Collaborators

• University Hospital, Brest: lead

Study Sites (1)

Chu Brest

Brest, 29609, France

Location

MeSH Terms

Conditions

Rheumatic Fever; Polymyalgia Rheumatica

Condition Hierarchy (Ancestors)

Streptococcal Infections; Gram-Positive Bacterial Infections; Bacterial Infections; Bacterial Infections and Mycoses; Infections; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Muscular Diseases

Study Officials

• Solène QUERELLOU

  CHU Brest

  STUDY DIRECTOR

Central Study Contacts

Solène QUERELLOU

CONTACT

0298223080; solene.querellou@chu-brest.fr

Chloé QUERE

CONTACT

chloe.quere@chu-brest.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 13, 2024
• First Posted: August 16, 2024
• Study Start: September 1, 2024
• Primary Completion: December 31, 2024
• Study Completion: December 31, 2024
• Last Updated: August 20, 2024

Record last verified: 2024-06

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: Data will be available beginning three years and ending fifteen years following the final study report completion
• Access Criteria: Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement

Locations

FR (1)